Cleared Traditional

K101625 - COHEN CROSSOVER CATHETER

K101625 is the FDA 510(k) clearance for COHEN CROSSOVER CATHETER by Vascular Solutions, Inc.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 40-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
40d
Days
Class 2
Risk

K101625 is an FDA 510(k) clearance for the COHEN CROSSOVER CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Vascular Solutions, Inc. (Minneapolis, US). The FDA issued a Cleared decision on July 19, 2010 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vascular Solutions, Inc. devices

Submission Details

510(k) Number K101625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 09, 2010
Decision Date July 19, 2010
Days to Decision 40 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 125d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 269
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K101625.
MODIFIED CONCENTRIC MICROCATHETER
K111619 · Concentric Medical, Inc. · Jul 2011
MERIT MARQUIS FLOW SWITCH
K110643 · Merit Medical Systems, Inc. · Jul 2011
EDWARDS LIFESCIENCES LEFT ATRIAL PRESSURE MONITOR CATHETER
K110103 · Edwards Lifesciences, LLC · Feb 2011
VIEWFLEX PLUS ICE CATHETER
K101239 · St Jude Medical · Jun 2010
IMPRESS ANGIOGRAPHIC CATHETER WITH HYDROPHILIC COATING
K093004 · Merit Medical Systems, Inc. · Feb 2010
ANGIOGRAPHIC CATHETER, MODEL ANGIOS
K092118 · Oscor, Inc. · Jan 2010